Who
Antony Koblish
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, TELA Bio; President & CEO, Orthovita.
In numbers
- Trades disclosed
- 61
- Buys
- 4
- Sells
- 0
- Bought
- $296K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 6 Mar 2007
- Last trade
- 24 Feb 2026
- Last filed
- 24 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Feb 2026filed 24 Feb 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $3,0623,900 at $0.7852 | filing |
| 24 Feb 2026filed 24 Feb 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $3,0813,900 at $0.79 | filing |
| 23 Feb 2026filed 24 Feb 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $8,90911,631 at $0.766 | filing |
| 23 Feb 2026filed 24 Feb 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $8,95611,631 at $0.77 | filing |
| 21 Feb 2026filed 24 Feb 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $8,96312,494 at $0.7174 | filing |
| 21 Feb 2026filed 24 Feb 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $8,99612,494 at $0.72 | filing |
| 20 Feb 2026filed 24 Feb 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —176,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —261,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —261,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —176,000 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $468384 at $1.22 | filing |
| 24 Feb 2025filed 25 Feb 2025 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $15K5,772 at $2.65 | filing |
| 23 Feb 2025filed 25 Feb 2025 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $32K11,631 at $2.72 | filing |
| 21 Feb 2025filed 25 Feb 2025 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —219,000 at $0.00 | filing |
| 21 Feb 2025filed 25 Feb 2025 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —149,000 at $0.00 | filing |
| 24 Oct 2024filed 24 Oct 2024 | TELA TELA BioMedical Devices | SEC FORM 4 Bought | $200K88,888 at $2.25 | filing |
| 31 Mar 2024filed 2 Apr 2024 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $2,183385 at $5.67 | filing |
| 24 Feb 2024filed 27 Feb 2024 | TELA TELA BioMedical Devices | SEC FORM 4 Code F | $40K5,726 at $7.07 | filing |
| 23 Feb 2024filed 27 Feb 2024 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —113,200 at $0.00 | filing |
| 23 Feb 2024filed 27 Feb 2024 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
News
TELA Bio (NASDAQ:TELA) versus Shoulder Innovations (NYSE:SI) Head to Head SurveyTELA · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Antony Koblish; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.